Every day, clinical labs need to quickly deliver the most reliable, actionable answers to physicians, even as they operate on tight budgets. Defining a flexible approach to manage these demands is critical for labs to operate with increasing efficiency.
Whether you need a streamlined, sample to answer platform or high-volume multiplexed assays, we can help.
We are the only molecular diagnostics developer providing both targeted and syndromic clinical tests for infectious diseases — so you never have to compromise on diagnostic performance, cost, or turnaround time to generate results.
From low-volume microbiology labs to high-capacity reference labs and everything in between, Luminex offers flexible solutions to meet the clinical, operational, and economic needs of your healthcare system.
VERIGENE bloodstream tests provide cost-effective bacterial identification and antibiotic resistance determination directly from positive blood culture bottles up to 48 hours faster than conventional methods.
Gram-Positive Blood Culture
Gram-Negative Blood Culture
Women’s health, particularly in the area of infectious diseases, is critically important not only to women but also their partners and children. When health issues arise, it’s important to get reliable and fast answers for patients.
ARIES® GBS Assay
ARIES® HSV 1&2 Assay*
MultiCode®-RTx HSV 1&2 Kit
xMAP® MultiFLEX™ Zika RNA Assay
Our respiratory portfolio empowers clinicians to implement a flexible and scalable algorithm to manage the evolving needs of their healthcare system.
ARIES® Bordetella Assay
ARIES® Flu A/B & RSV Assay
NxTAG® Respiratory Pathogen Panel
VERIGENE® Respiratory Pathogens Flex Test (RP Flex)
xTAG® Respiratory Viral Panel
xTAG® Respiratory Viral Panel FAST v2
Diarrhea caused by gastrointestinal pathogens represents a significant clinical concern for providers and patients, and a workflow burden for the laboratory.
ARIES® C. difficile Assay
VERIGENE® Clostridium difficile Test (CDF)
VERIGENE® Enteric Pathogens Test (EP)
xTAG® Gastrointestinal Pathogen Panel
* WARNING: The ARIES® HSV 1&2 Assay is not FDA cleared for use with cerebrospinal fluid (CSF). The assay is not intended to be used for prenatal screening.